Free Trial
NASDAQ:BSCX

Invesco BulletShares 2033 Corporate Bond ETF (BSCX) Price, Holdings, & News

Invesco BulletShares 2033 Corporate Bond ETF logo
$21.17 +0.02 (+0.09%)
As of 09:59 AM Eastern

About Invesco BulletShares 2033 Corporate Bond ETF (NASDAQ:BSCX)

Advanced

Key Stats

Today's Range
$21.17
$21.18
50-Day Range
$20.92
$21.56
52-Week Range
$20.52
$21.86
Volume
10,016 shs
Average Volume
212,296 shs
Market Capitalization
$959.00 million
Assets Under Management
$985.96 million
Dividend Yield
4.87%
Net Expense Ratio
0.10%
Aggregate Rating
N/A

ETF Overview

Invesco BulletShares 2033 Corporate Bond ETF Expenses

TypeBSCXInvestment Grade ETFsFixed Income ETFsNASDAQ ETFsAll ETFs
Management Fee0.10%0.23%0.32%0.54%0.53%
Other Expenses0.00%0.11%0.27%0.51%0.55%
Total Expense0.10%0.26%0.40%0.73%0.73%
Fee Waiver0.00%-0.14%-0.27%-0.50%-0.61%
Net Expense0.10%0.24%0.36%0.62%0.60%
Receive BSCX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invesco BulletShares 2033 Corporate Bond ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BSCX ETF News Headlines

Microscopic Footage Shows Immune Cells Attacking Cancer
Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using its TriKE platform, which is designed to keep Natural Killer cells active and targeted longer than standard approaches. The company's next-generation version shows potential for 10-40x greater potency and has already cleared an important FDA milestone. Watch the microscopic footage and see what the next catalyst could mean for investors.tc pixel
See More Headlines

BSCX ETF - Frequently Asked Questions

Invesco BulletShares 2033 Corporate Bond ETF's stock was trading at $21.46 on January 1st, 2026. Since then, BSCX stock has decreased by 1.4% and is now trading at $21.17.

Invesco BulletShares 2033 Corporate Bond ETF's top institutional shareholders include Janney Montgomery Scott LLC (1.41%), Parkway Wealth Management Group LLC (1.06%), BCS Wealth Management (0.97%) and Clark Asset Management LLC (0.95%).

Shares of BSCX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco BulletShares 2033 Corporate Bond ETF investors own include CoinShares Valkyrie Bitcoin Fund (BRRR), Dutch Bros (BROS), Bridgeline Digital (BLIN), Aterian (ATER), Apyx Medical (APYX), Annexon (ANNX) and Aemetis (AMTX).

Fund Details

Issuer
Invesco
Fund Name
Invesco BulletShares 2033 Corporate Bond ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:BSCX
Inception Date
9/20/2023
Fund Manager
Peter Hubbard, Cynthia Madrigal, Gregory Meisenger, Jeremy Neisewander
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Fixed Income
Benchmark
Invesco BulletShares USD Corporate Bond 2033 Index
Category
Corporate
Focus
Investment Grade
Development Level
Developed Markets
Region
North America
Number of Holdings
275

Fund Statistics

Assets Under Management
$985.96 million
Average Daily Volume
$0.00
Discount/Premium
0.01%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Invesco Capital Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Invesco Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Flow Traders

Options

Optionable
N/A
Short Interest
54,500 shs

Miscellaneous

Beta
0.30
Creation Unit
100,000
Creation Fee
$250.00
Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Top 10 BSCX Holdings

  • Amgen Inc. 5.25%
    Holding Weight: 1.62%
  • Amazon.com, Inc. 4.55%
    Holding Weight: 1.46%
  • AT&T Inc 2.55%
    Holding Weight: 1.18%
  • Alphabet Inc. 4.4%
    Holding Weight: 1.09%
  • Oracle Corp. 5.35%
    Holding Weight: 1.08%
  • Salesforce Inc. 5.2%
    Holding Weight: 1.01%
  • Abbott Laboratories 4.3%
    Holding Weight: 1.00%
  • T-Mobile USA, Inc. 5.05%
    Holding Weight: 0.97%
  • Enbridge Inc. 5.7%
    Holding Weight: 0.89%
  • Philip Morris International Inc. 5.375%
    Holding Weight: 0.86%

BSCX Sector Exposure

BSCX Industry Exposure


This page (NASDAQ:BSCX) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners